Canadian Dollar: Firmer against US Dollar – Societe Generale
Societe Generale strategists highlight that USD/CAD is tactically expensive versus the 2-year spread and has recently met resistance near 1.4250 before retracing toward 1.4130. They view this area as potential support but warn that a break lower could trigger a deeper pullback toward 1.4075 and the 50-DMA near 1.3950, framing near-term downside risks for the pair.
Key support eyed near 1.4130
"USD/CAD encountered interim resistance around 1.4250 last month and has since retraced toward the upper boundary of its previous broad consolidation range near 1.4130, which could serve as a potential support."
"It will be interesting to observe whether the pair can hold above this support."
"Should a break below 1.4130 materialize, USD/CAD may embark on a deeper pullback."
"The next objectives could be located at projections of 1.4075, followed by the 50-DMA near 1.3950."
"USD/CAD expensive based on 2y spread"
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Apple Pre-sale Tracker: iPhone 18 Pro Series Shows Weak Overseas Demand Signals, Duo Review Positive but Hardware Lags Behind
According to a survey by Jefferies, after the launch of the iPhone 18 Pro, delivery wait times in the four major markets—the US, UK, Germany, and Japan—have shortened by 5 to 11 days compared to last year, with no wait time in the US. Given stable production capacity, this is a clear sign of weak demand. Although the China and Hong Kong markets have performed better against the trend, there are still suspicions of speculative stockpiling. The new foldable Duo has been praised for its software experience, but its $2,000 price tag comes with a 254-gram body and dual-camera setup, leaving its hardware lagging significantly behind Android competitors. Jefferies maintains an "underperform" rating, with a target price implying a 21% downside from the current level.
UBS Health Benefit Survey: Elevance Health (ELV.US) Leads, U.S. Employers Prepare for Rising Medical Costs
In the annual survey by UBS for employee benefits management institutions, Elevance Health (ELV.US) emerged as the highest-rated US health insurance company.
LINK Targets $11.50 as LINK/BTC Approaches a Critical Breakout Zone
Solana breaks resistance, holds above $100 as analysts target $147
Crypto prices
More
